Helius medical technologies.

About Helius Medical Technologies, Inc.Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology ...Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company’s product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short …Helius Medical Technologies, Inc. to Release Third Quarter 2023 Financial Results on November 9, 2023; Announces Extended Cash Runway into Q2 2024. Globe Newswire - Nov 2, 2023, 5:05PM.Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...

Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...Sep 13, 2023 · About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms and promote neuroplasticity, improving the lives of people dealing with neurologic diseases.

Helius Medical Technologies is a neurotech company focused on neurological wellness. The Company’s purpose is to develop, license and acquire unique and non-invasive platform including the ...

We have acted as counsel to Helius Medical Technologies, Inc., a Delaware corporation (the “Company”), in connection with the preparation and filing with the Securities and Exchange Commission (the “Commission”) of a Registration Statement on Form S-8 (the “Registration Statement”) for the registration under the Securities Act of ...Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms and promote neuroplasticity, improving the lives of people dealing with neurologic diseases. ...Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...Mar 22, 2023 · Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ... As of September 30, 2023, we had $6.6 million in cash and no debt and $4 million in proceeds receivable from warrant exercises as of September 30, 2023, and we expect our cash runway to extend ...

Nov 9, 2023 · NEWTOWN, Pa., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that Dane Andreeff, President and Chief November 30, 2023 PDF Version Read More

Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability ...

His experience spans established medical device technologies as well as new novel technologies including AI. Mr. Picciano joined Helius Medical, Inc in late 2018 and serves as the senior vice president of product development, regulatory affairs, and quality. He has helped attain PoNS US FDA breakthrough device designations in multiple sclerosis ... Nov 24, 2023 · Helius Medical Technologies, Inc. to Release Third Quarter 2023 Financial Results on November 9, 2023; Announces Extended Cash Runway into Q2 2024. -- Expects to report Q3 revenues in range of $140 - $150 thousand, reflecting the expected decrease in U.S. sales with the conclusion of the Patient Therapy Access Program (PTAP) on June 30, 2023 Medical equipment donations are a great way to help those in need. Whether you’re donating to a hospital, clinic, or other medical facility, there are a few things you should know before you donate. Here’s what you need to know about donati...Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...The Portable Neuromodulation Stimulator (PoNS®) is an innovative technology in treating gait and balance deficit in individuals with neurological disorders, to improve function. The PoNS device is an innovative technology to help individuals with chronic neurological symptoms of disease or trauma. It includes a controller and mouthpiece that ...New York Presbyterian Hospital is one of the leading medical institutions in the world. It is renowned for its cutting-edge technology, which has revolutionized patient care and treatment. From advanced imaging techniques to robotic surgery...

AI is frequently cited as a miracle worker in medicine, especially in screening processes, where machine learning models boast expert-level skills in detecting problems. But like so many technologies, it’s one thing to succeed in the lab, q...Helius Medical Technologies, Inc. -- Expects to report Q3 revenues in range of $140 - $150 thousand, reflecting the expected decrease in U.S. sales with the conclusion of the Patient Therapy ...Helius Medical Technologies (NASDAQ:HSDT) ... Helius reported revenue in the fourth quarter of $2022 to be $282,000 and full-year revenue in 2022 to be $787,000. The company recorded a net loss ...May 11, 2023 · About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability to compensate and promotes neuroplasticity, aiming to improve the lives of people dealing with neurologic ... Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform …

Helius Medical Technologies Inc does not have a meaningful P/E due to negative earnings over the last 12 trailing months. Helius Medical Technologies Inc’s trailing 12-month revenue is $0.9 million with a % profit margin. Year-over-year quarterly sales growth most recently was 200.0%.Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...

A Helius Medical Technologies medical device that stimulates the brain by sending electrical stimulation to the tongue has received FDA clearance for multiple sclerosis patients. The company says ...Helius Medical Technologies is a publicly traded company on the NASDAQ (HSDT) in the United States. Visit the About page to see how our company has …Helius Medical Technologies, Inc. Class A Common Stock (DE) (HSDT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms and promote neuroplasticity, improving the lives of people ...Whether you’re interested in reviewing information doctors have collected about you or you need to verify a specific component of a past treatment, it can be important to gain access to your medical records online. This guide shows you how ...As previously disclosed, the employment of Joyce LaViscount, Chief Operating Officer of Helius Medical Technologies, Inc. (the “Company”) ended on July 20, 2021 (the “Separation Date”). In connection with Ms. LaViscount’s notice of intent to resign for “Good Reason” under her employment agreement dated October 19, 2015, as …Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...

Jun 20, 2023 · About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability to compensate and promote neuroplasticity, improving the lives of people dealing with neurologic diseases.

Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability ...

Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...Accuracy and authority are important when it comes to any health-related information you find online, so if you’re searching for a glossary of medical terms, it’s best to be discerning with where you get your information.About Helius Medical Technologies, Inc.Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology ...Helius Medical Technologies is a neurotech company focused on neurological wellness. The Company’s purpose is to develop, license and acquire unique and non-invasive platform technologies that ...About Helius Medical Technologies, Inc. Helius Medical Technologies is a neurotech company focused on neurological wellness. The Company’s purpose is to develop, license and acquire unique and non-invasive platform technologies that …Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability ...Together, we work passionately to develop and deliver easy-to-use technology for neurological wellness. If you want to join us in our mission, we want to hear from you. …Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability ...

Nov 24, 2023 · Helius Medical Technologies, Inc. (NASDAQ:HSDT) announced its earnings results on Thursday, November, 9th. The company reported ($5.49) EPS for the quarter. The firm earned $0.14 million during the quarter. Helius Medical Technologies had a negative net margin of 1,602.40% and a negative trailing twelve-month return on equity of 232.74%. NEWTOWN, Pa., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced the participation of Prue Plummer PhD, PT, Professor in the Department of Physical Therapy in the School of Health and …Helius Medical Technologies, Inc. is a neurotech company in the medical device field. It is focused on neurologic deficits using orally applied technology platform that amplifies the brainâ s ability to engage physiologic compensatory mechanisms enhancing the lives of people dealing with neurologic diseases.Instagram:https://instagram. lockheed martin srock1943 steel penny with no mint markmain drain insuranceai based trading platform Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...On February 16, 2020, Mr. Thomas Griffin notified the Board of Directors (the “Board”) of Helius Medical Technologies, Inc. (the “Company”) of his intent not to run for reelection at the Company’s 2020 annual meeting of stockholders (the “Annual Meeting”). His term as director of the Company will conclude at the Annual Meeting. Mr. nysearca physshort term medical insurance texas Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...Chief Financial Officer. Mr. Mathiesen is an accomplished senior executive and director of public and privately held companies with broad experience in the biopharmaceutical, medical device, semiconductor capital equipment, and water filtration markets. Mr. Mathiesen has served as director and audit committee chair of Panbela Therapeutics, Inc ... rty future Ethical considerations involve researchers who undertake studies of human behavior, medical advances or technological devices, while taking into account how humans may feel about the potential outcomes of the research.Chief Financial Officer. Mr. Mathiesen is an accomplished senior executive and director of public and privately held companies with broad experience in the biopharmaceutical, medical device, semiconductor capital equipment, and water filtration markets. Mr. Mathiesen has served as director and audit committee chair of Panbela Therapeutics, Inc ...